NEW YORK, Feb 5 - Pyrosequencing of Uppsala, Sweden said Monday the Wallenberg Consortium North was the first customer to sign up for its Preferred Technology Program for the analysis of SNPs.
The WCN, a consortium that includes the proteomics, bioinformatics, and genomics branches of Sweden’s Royal Institute of Technology, the Karolinska Institute, the University of Uppsala, the University of Stockholm, and the University of Umea, intends to use the PTP to analyze SNPs associated with human and animal diseases. The consortium has committed $200 million for genomics research over the next five years.
Financial terms of the deal were not disclosed.
" What is particularly attractive about PTP is its highly customized offering which meets our specific needs – from sample preparation robotics through to SNP scoring,” Joakim Lundeberg, director of the Royal Institute of Technology’s genome center, said in a statement. “Going forward, it also allows us to ramp up our capacity to analyze samples using the same Pyrosequencing technology."
Pyrosequencing's PTP is a high-throughput system that runs on 384 well microplates and can score up to to 100,000 SNPs a day, the company said. The system uses the same “sequencing by synthesis” employed in the company’s PSQ 96 system. PTP also includes software, reagent kits, and sample preparation robotics.
" PTP is a truly collaborative offering in which we work closely with customers like the Wallenberg Consortium to assess their sequencing needs and customize our product to meet special requirements,” said Erik Wallden, CEO of Pyrosequencing.
Pyrosequencing’s customers for the PSQ 96 include AstraZeneca, Harvard Center for Cancer Prevention and the National Institutes of Health.